Abeona Therapeutics Financial Overview
Abeona Therapeutics's market cap is currently $299.14M. The company's EPS TTM is $-0.1; its P/E ratio is 4.60; Abeona Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
